Paul Kelly - Jan 3, 2022 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Director
Signature
/s/ Paul E. Kelly
Stock symbol
RLMD
Transactions as of
Jan 3, 2022
Transactions value $
-$64,800
Form type
4
Date filed
1/5/2022, 04:01 PM
Previous filing
Dec 21, 2021
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLMD Common Stock Options Exercise -$64.8K -20K -9.65% $3.24 187K Jan 3, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Options to purchase common stock Options Exercise $0 -20K -39.6% $0.00 30.5K Jan 3, 2022 Common Stock 20K $3.24 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period.
F2 Not applicable.